Navigation Links
Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program
Date:5/28/2009

previous clinical study, a subset of patients with recurrent glioblastoma treated with Cotara achieved a median survival of 38 weeks, a 58% increase over the historical median survival time of 24 weeks for patients treated with standard of care therapy. In this study, 25% of 28 recurrent patients survived for more than a year post-treatment and 10% of patients survived for more than three years. These data are considered a promising development in this deadly disease. Cotara has been granted orphan drug status and fast track designation for the treatment of glioblastoma multiforme and anaplastic astrocytoma by the U.S. Food and Drug Administration. A Phase I dosimetry trial in GBM patients in the U.S. has completed patient enrollment and a Phase II safety and efficacy trial in GBM patients in India is ongoing. For more information on the trials, visit www.clinicaltrials.gov.

About Peregrine Pharmaceuticals

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative product candidates in clinical trials for the treatment of cancer and serious virus infections. The company is pursuing three separate clinical programs in cancer and hepatitis C virus (HCV) infection with its lead product candidates bavituximab and Cotara(R). Peregrine also has in-house manufacturing capabilities through its wholly owned subsidiary Avid Bioservices, Inc. (www.avidbio.com), which provides development and bio-manufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at www.peregrineinc.com.

Safe Harbor Statement: Statements in this press release which are not purely historical, including statements regarding Peregrine Pharmaceuticals' intentions, hopes, beliefs,
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQs Minimum Bid Price Rule
2. Peregrine Pharmaceuticals to Report Third Quarter FY 2009 Financial Results
3. Peregrine Pharmaceuticals Bavituximab Achieves Primary Endpoint in First Stage of Phase II Breast Cancer Study
4. Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2009
5. Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies
6. Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals Bavituximab to Cure Lethal Virus Infections
7. Peregrine Pharmaceuticals Announces Positive Data From Cotara(R) Brain Cancer Trials
8. Peregrine Pharmaceuticals Receives Approval to Begin New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
9. Positive Results From Peregrine Pharmaceuticals Bavituximab Phase l HCV Trial Presented at AASLD Meeting
10. Poniard Pharmaceuticals Announces Positive Efficacy and Safety Data From Phase 2 Clinical Trial of Picoplatin in Men With Metastatic Prostate Cancer
11. Verus Pharmaceuticals Announces a Lawsuit Against AstraZeneca AB and Tika Lakemedel AB
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... When a child, deaf person or elderly ... keep them from wandering off. "In order to eliminate this ... three inventors from Yulee, Fla. , The BUZZ ME helps ... and deters them from wandering off. This avoids stress and ... use and compact, the device can be produced in design ...
(Date:10/2/2014)... 2014 The Business Intelligence Group ... Awards for Business program. The BIG Awards specialize ... proprietary judging process scored by well-known and experienced ... “The winners this year epitomize what is going ... of the Business Intelligence Group. “The sheer amount ...
(Date:10/2/2014)... News) -- Scientists have pinpointed a molecule that may ... The researchers say this finding could offer a ... these attacks. Most asthma attacks (80 percent to ... airways, according to the British researchers. Most of these ... common cold. The researchers found that a specific ...
(Date:10/2/2014)... HealthDay Reporter WEDNESDAY, Oct. 1, 2014 (HealthDay News) ... -- may face an increased risk of dying in the next ... 3,000 older Americans, researchers found those who were unable to detect ... times as likely to die in the next five years, versus ... -- the inability to distinguish odors -- was a bigger predictor ...
(Date:10/1/2014)... is strongly associated with Alzheimer,s disease; however, researchers are ... the causal agent of the onset and development of ... that beta-amyloid is not harmful when found in isolation ... self-assembles to form the so-called amyloid fibrils , "We ... but with multiple ones because each aggregate of peptide, ...
Breaking Medicine News(10 mins):Health News:Innovation Dominant Theme among 2014 Big Awards for Business Winners and Finalists 2Health News:New Clues to How Colds Can Spur Asthma Attacks 2Health News:Could a Fading Sense of Smell Point to Earlier Death? 2Health News:Could a Fading Sense of Smell Point to Earlier Death? 3Health News:Laying siege to beta-amyloid, the key protein in Alzheimer's disease 2
... NEW YORK, March 19 The Department of ... York is a 2009 winner of the American Pain Society,s ... number of pain centers for excellence and innovation in interdisciplinary ... acknowledges the many challenges encountered in maintaining a team of ...
... its recent analysis of the field of orthopedic tissue ... with the 2009 North American Technology Innovation of the ... scaffold for use in orthopedic and spine tissue engineering. ... that it provides a suitable matrix for cell growth ...
... Dr. Friedberg vs. The American Society of Anesthesiologists, Action ... doctor against 43,000 doesn,t seem like very fair odds. ... cosmetic surgery anesthesia, Dr. Barry Friedberg, set the stage ... Society of Anesthesiologists, (ASA) March 9 press release in ...
... Legislative Language to Health Provisions , ... Newport Beach, ... human resource and benefits management services , today released a ... In the face of the significant changes from Barack Obama’s ...
... transcription services to group practices, multi-specialty clinics and community health ... Neurological Associates. , ... Scottsdale, AZ ... provider of medical transcription services to group ...
... ALCMI,s founding organization, the Bonnie J. Addario Lung Cancer ... advertising campaign to raise $20 from one million people in ... CBS Outdoor and friends of the Foundation to raise awareness ... billboards in New York City, Los Angeles, Washington, D.C., San ...
Cached Medicine News:Health News:The Department of Pain Medicine and Palliative Care at Beth Israel Medical Center is Named 2009 Center of Excellence Award Winner by the American Pain Society 2Health News:Frost & Sullivan Lauds Pioneer Surgical Technology for Development of Tissue Scaffold E-Matrix 2Health News:Frost & Sullivan Lauds Pioneer Surgical Technology for Development of Tissue Scaffold E-Matrix 3Health News:Frost & Sullivan Lauds Pioneer Surgical Technology for Development of Tissue Scaffold E-Matrix 4Health News:Dr. Barry Friedberg comments on David vs. Goliath: Who's Really in the Pursuit of Patient Safety & Satisfaction? 2Health News:Secova Reports Healthcare Provisions In The Stimulus Bill 2Health News:Secova Reports Healthcare Provisions In The Stimulus Bill 3Health News:MxSecure, Inc. Completes Custom Document Management Interface for Roanoke Neurological Associates 2Health News:MxSecure, Inc. Completes Custom Document Management Interface for Roanoke Neurological Associates 3Health News:Joan Gaeta Lung Cancer Foundation Donates $15,000 to Addario Lung Cancer Medical Institute (ALCMI) for Lung Cancer Research 2Health News:Joan Gaeta Lung Cancer Foundation Donates $15,000 to Addario Lung Cancer Medical Institute (ALCMI) for Lung Cancer Research 3
(Date:10/2/2014)... , Oct. 2, 2014  MJ Freeway®, the ... two important webinars detailing upcoming legalization efforts in ... and Nevada .  The success of ... of marijuana legalization on the national level. ... and Co-Founder of the Marijuana Policy Project, an organization ...
(Date:10/2/2014)...  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ... conference call to provide an update on the ... Rx in infants and children with spinal ... the morning (CEST) of Friday, October 10 at ... GermanyWhen:Friday, October 10 at 11:30 a.m. ET / ...
(Date:10/1/2014)... 2014  Abaxis, Inc. (NasdaqGS: ABAX ), ... for the medical, research, and veterinary markets worldwide and ... markets in the United States , ... agreement with Patterson Veterinary Supply. Patterson ... of Abaxis veterinary products throughout the United ...
Breaking Medicine Technology:MJ Freeway to Host Educational Webinars Regarding Crucial Marijuana Legalization Efforts in Alaska, Nevada and Oregon 2Isis Pharmaceuticals to Host Webcast to Discuss ISIS-SMN Rx Results Presented at the World Muscle Society Congress 2Abaxis Announces Distribution Agreement with Patterson Veterinary Supply 2Abaxis Announces Distribution Agreement with Patterson Veterinary Supply 3Abaxis Announces Distribution Agreement with Patterson Veterinary Supply 4
... PAUL, Minn., Feb. 22, 2011 New research shows people ... to be at an increased risk of developing Parkinson,s disease, ... at the American Academy of Neurology ,s 63rd Annual ... Benzedrine and dexedrine are amphetamines often prescribed to increase ...
... Grifols, a global healthcare company and biopharmaceutical manufacturer ... long-term cooperative agreement with the diagnostics business of ... products in the US.  Under the terms of ... immunohematology instruments, assays and other products following US ...
Cached Medicine Technology:Using Amphetamines May Increase Risk of Parkinson's Disease 2Grifols Signs Cooperative Agreement for Commercialization of Immunohematology Diagnostic Products in the US 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: